Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia

Human Molecular Genetics

Volumn 23, Issue 3, 2014, Pages 590-601

  Meissner, Barbara ^a,b   Bartram, Thies ^a   Eckert, Cornelia ^c   Trka, Jan ^d   Panzer Grümayer, Renate ^e   Hermanova, Ivana ^d   Ellinghaus, Eva ^f   Franke, Andre ^f   Möricke, Anja ^a   Schrauder, André ^a   Teigler Schlegel, Andrea ^g   Dörge, Petra ^a   Von Stackelberg, Arend ^c   Basso, Giuseppe ^h   Bartram, Claus R ⁱ   Kirschner Schwabe, Renate ^c   Bornhäuser, Beat ^j   Bourquin, Jean Pierre ^j   Cazzaniga, Giovanni ^k   Hauer, Julia ^l   Attarbaschi, Andishe ^e   Izraeli, Shai ^m   Zaliova, Marketa ^b,d   Cario, Gunnar ^a   Zimmermann, Martin ^b   Avigad, Smadar ⁿ   Sokalska Duhme, Magdalena ^o   Metzler, Markus ^p   Schrappe, Martin ^a   Koehler, Rolf ⁱ   Te Kronnie, Geertruy ^h   Stanulla, Martin ^b   more..

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CHARLES UNIVERSITY   (Czech Republic)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF KIEL   (Germany)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^k UNIVERSITY OF MILANO BICOCCA   (Italy)

^l HEINRICH HEINE UNIVERSITY   (Germany)

^m SHEBA MEDICAL CENTER   (Israel)

ⁿ SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^o Olga Children's Hospital   (Germany)

^p UNIVERSITY HOSPITAL ERLANGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 20; CONTROLLED STUDY; DNA CONTENT; DRUG RESPONSE; FEMALE; GENDER BIAS; GENE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENOME; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RISK ASSESSMENT; RNA ISOLATION; SLX4IP GENE; TAL1 GENE; VDJ RECOMBINATION;

ADOLESCENT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; GENE DELETION; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECOMBINASES; REPRESSOR PROTEINS; V(D)J RECOMBINATION;

EID: 84892462125     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt447     Document Type: Article

References (45)

1. Pui, C.H., and Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. N. Engl. J. Med., 354, 166-178.
2. Redaelli, A., Laskin, B.L., Stephens, J.M., Botteman, M.F., and Pashos, C.L. (2006) A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur. J. Cancer Care (Engl), 14, 53-62.
3. Tower, R.L., and Spector, L.G. (2007) The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit. Rev. Clin. Lab. Sci., 44, 203-242.
4. Linabery, A.M., and Ross, J.A. (2008) Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer, 112, 416-432.
5. Schrappe, M., Valsecchi, M.G., Bartram, C.R., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B. et al. (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118, 2077-2084.
6. Conter, V., Bartram, C.R., Valsecchi, M.G., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Aricò , M., Zimmermann, M., Mann, G., De Rossi, G. et al. (2010) Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115, 3206-3214.
7. Greaves, M.F., and Wiemels, J. (2003) Origins ofchromosome translocations in childhood leukaemia. Nat. Rev. Cancer, 3, 639-649.
8. Zelent, A., Greaves,M., and Enver, T. (2004) Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene, 23, 4275-4283.
9. Gellert, M. (2002) V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem., 71, 101-132.
10. Schatz, D.G. (2004) V(D)J recombination. Immunol. Rev., 200, 5-11.
11. Raghavan, S.C., Kirsch, I.R., and Lieber, M.R. (2001) Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J. Biol. Chem., 276, 29126-29133.
12. Marculescu, R., Vanura, K., Montpellier, B., Roulland, S., Le, T., Navarro, J.M., Jäger, U., McBlane, F., and Nadel, B. (2006) Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair, 5, 1246-1258.
13. Waanders, E., Scheijen, B., van der Meer, L.T., van Reijmersdal, S.V., van Emst, L., Kroeze, Y., Sonneveld, E., Hoogerbrugge, P.M., van Kessel, A.G., van Leeuwen, F.N. et al. (2012) The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PLoS Genet., 8, e1002533. doi:10.1371/ journal.pgen.1002533.
14. Onozawa, M., and Aplan, P.D. (2012) Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy. Genes Chromosomes Cancer, 51, 525-535.
15. van der Velden, V.H., Hochhaus, A., Cazzaniga, G., Szczepanski, T., Gabert, J., and van Dongen, J.J. (2003) Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia, 17, 1013-1034.
16. Aplan, P.D., Lombardi, D.P., Ginsberg, A.M., Cossman, J., Bertness, V.L., and Kirsch, I.R. (1990) Disruption of the human SCL locus by 'illegitimate' V(D)J recombinase activity. Science, 250, 1426-1429.
17. Svendsen, J.M., Smogorzewska, A., Sowa, M.E., O'Connell, B.C., Gygi, S.P., Elledge, S.J., and Harper, J.W. (2009) Mammalian BTBD12/SLX4 assembles a holliday junction resolvase and is required forDNArepair. Cell, 138, 63-77.
18. Mullighan, C.G., Goorha, S., Radtke, I., Miller, C.B., Coustan-Smith, E., Dalton, J.D., Girtman, K., Mathew, S., Ma, J., Pounds, S.B. et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukemia. Nature, 446, 758-764.
19. Lilljebjörn, H., Soneson, C., Andersson, A., Heldrup, J., Behrendtz, M., Kawamata, N., Ogawa, S., Koeffler, H.P., Mitelman, F., Johansson, B. et al. (2010) The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias. Hum. Mol. Genet., 19, 3150-3158.
20. Tsai, A.G., and Lieber, M.R. (2010) Mechanisms of chromosomal rearrangement in the human genome. BMC Genomics, 11(Suppl. 1), S1.
21. Anderson, K., Lutz, C., van Delft, F.W., Bateman, C.M., Guo, Y., Colman, S.M., Kempski, H., Moorman, A.V., Titley, I., Swansbury, J. et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukemia. Nature, 469, 356-361.
22. Stirewalt, D.L., Meshinchi, S., Kopecky, K.J., Fan, W., Pogosova-Agadjanyan, E.L., Engel, J.H., Cronk, M.R., Dorcy, K.S., McQuary, A.R., Hockenbery, D. et al. (2008) Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer, 47, 8-20.
23. Bungaro, S., Dell'Orto, M.C., Zangrando, A., Basso, D., Gorletta, T., Lo Nigro, L., Leszl, A., Young, B.D., Basso, G., Bicciato, S. et al. (2009) Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer, 48, 22-38.
24. Mullighan, C.G., Miller, C.B., Radtke, I., Phillips, L.A., Dalton, J., Ma, J., White, D., Hughes, T.P., Le Beau, M.M., Pui, C.H. et al. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature, 453, 110-114.
25. Dörge, P., Meissner, B., Zimmermann, M., Möricke, A., Schrauder, A., Bouquin, J.P., Schewe, D., Harbott, J., Teigler-Schlegel, A., Ratei, R. et al. (2013) IKZF1 Deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica, 98, 428-432.
26. Fish, E.N. (2008) The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol., 8, 737-744.
27. Ober, C., Loisel, D.A., and Gilad, Y. (2008) Sex-specific genetic architecture of human disease. Nat. Rev. Genet., 9, 911-922.
28. Medina, K.l., Strasser, A., and Kincade, P.W. (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood, 95, 2059-2067.
29. Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.G., Ohgi, K., Zhang, J., Rose, D.W., Fu, X.D., Glass, C.K. et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell, 139, 1069-1083.
30. Ludwig, W.D., Rieder, H., Bartram, C.R., Heinze, B., Schwartz, S., Gassmann, W., Löffler, H., Hossfeld, D., Heil, G., Handt, S. et al. (1998) Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood, 92, 1898-1909.
31. Hiddemann, W., Wörmann, B., Ritter, J., Thiel, E., Göhde, W., Lahme, B., Henze, G., Schellong, G., Riehm, H., and Büchner, T. (1986) Frequency and clinical significance ofDNAaneuploidy in acute leukemia. Ann. N. Y. Acad. Sci., 468, 227-240.
32. Harbott, J., Ritterbach, J., Ludwig, W.D., Bartram, C.R., Reiter, A., and Lampert, F. (1993) Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials. Recent Results Cancer Res., 131, 123-132.
33. Schlieben, S., Borkhardt, A., Reinisch, I., Ritterbach, J., Janssen, J.W., Ratei, R., Schrappe, M., Repp, R., Zimmermann, M., Kabisch, H. et al. (1996) Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL): a prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia, 10, 957-963.
34. Viehmann, S., Borkhardt, A., Lampert, F., and Harbott, J. (1999) Multiplex PCR: a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia. Ann. Hematol., 78, 157-162.
35. Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M.G., Ludwig, W.D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F. et al. (1997) Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials: Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood, 90, 571-577.
36. Volejnikova, J., Mejstrikova, E., Valova, T., Reznickova, L., Hodonska, L., Mihal, V., Sterba, J., Jabali, Y., Prochazkova, D., Blazek, B. et al. (2011) Minimal residual disease in peripheral blood at day 15 identifies subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis. Haematologica, 96, 1815-1821.
37. Bader, P., Kreyenberg, H., Henze, G.H., Eckert, C., Reising, M., Willasch, A., Barth, A., Borkhardt, A., Peters, C., Handgretinger, R. et al. (2009) Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J. Clin. Oncol., 27, 377-384.
38. Eckert, C., Flohr, T., Koehler, R., Hagedorn, N., Moericke, A., Stanulla, M., Kirschner-Schwabe, R., Cario, G., Stackelberg, A., Bartram, C.R. et al. (2011) Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment. Leukemia, 25, 1305-1313.
39. Mullighan, C.G., Phillips, L.A., Su, X., Ma, J., Miller, C.B., Shurtleff, S.A., and Downing, J.R. (2008) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science, 322, 1377-1380.
40. Pongers-Willemse, M.J., Seriu, T., Stolz, F., d'Aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C.R., Panzer-Grümayer, E.R., Biondi, A. et al. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTEDACTION: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 110-118.
41. von Goessel, H., Jacobs, U., Semper, S., Krumbholz, M., Langer, T., Keller, T., Schrauder, A., van der Velden, V.H., van Dongen, J.J., Harbott, J. et al. (2009) Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia. Leuk. Res., 33, 1082-1088.
42. Kaplan, E.L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
43. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170.
44. Kalbfleisch, J.D., and Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, pp. 163-188.
45. Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat., 16, 1141-1154.